Spots Global Cancer Trial Database for germline mutation
Every month we try and update this database with for germline mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adherence to Intensive Surveillance for Hereditary Breast Cancer | NCT00582803 | Breast Cancer | 25 Years - | Memorial Sloan Kettering Cancer Center | ||
| Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO | NCT05033756 | Malignant Neopl... Breast Cancer | Pembrolizumab I... Olaparib Oral T... | 18 Years - | Institut fuer Frauengesundheit | |
| Integrative Sequencing In Germline and Hereditary Tumours | NCT03857594 | Hereditary Canc... High-Risk Mutation Germline Mutati... | 18 Years - | University Health Network, Toronto | ||
| Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria | NCT03046849 | Lynch Syndrome | next-generation... | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial | NCT03553004 | Pancreatic Canc... | Niraparib Treat... | 18 Years - | University of Kansas Medical Center | |
| A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment | NCT03092128 | Gastrointestina... Germline Mutati... Somatic Mutatio... Plasma Concentr... | 18 Years - 80 Years | Sun Yat-sen University | ||
| A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment | NCT03092128 | Gastrointestina... Germline Mutati... Somatic Mutatio... Plasma Concentr... | 18 Years - 80 Years | Sun Yat-sen University | ||
| Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial | NCT03553004 | Pancreatic Canc... | Niraparib Treat... | 18 Years - | University of Kansas Medical Center | |
| Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa | NCT01670500 | Breast Cancer | Cisplatin Cyclophosphamid... Doxorubicin | 18 Years - | Dana-Farber Cancer Institute | |
| Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria | NCT03046849 | Lynch Syndrome | next-generation... | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Adherence to Intensive Surveillance for Hereditary Breast Cancer | NCT00582803 | Breast Cancer | 25 Years - | Memorial Sloan Kettering Cancer Center | ||
| PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness | NCT04995198 | Prostate Cancer | Genetic Testing Genetic Counsel... Patient Reporte... | 18 Years - | Prostate Cancer Clinical Trials Consortium |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
